Product Images Divalproex Sodium

This is a medication with the NDC code 65862-403-10 that contains Divalproex Sodium in delayed-release tablets of 500 mg. The usual dosage and packaging information is provided on the package enclosure. The medication guide should be provided separately to each patient by the pharmacist. The package is child-resistant and should be stored at room temperature. The manufacturer is Aurobindo.*

This is a chart or a figure showing the % reduction in CPS rate with High Dose and Low Dose on the X-axis and % of Patients on the Y-axis. There are three categories of patients - Improvement, No Change, and Worsening.*

This is a medication label for Divalproex Sodium Delayed-Release Tablets USP. The tablets come in a bottle of 100 and contain 125 mg of valproic acid. The label includes information on dosage, storage temperature, and packaging requirements. The medication is distributed by Aurobindo Pharma USA, Inc. and made in India. NDC number is provided for reference.*

This is a prescription drug called Divalproex Sodium in the form of delayed-release tablets. The package contains 400 tablets (10 x 10 Unit-Dose) and the standard dosage can be found in the package enclosure. It should be stored between 20° to 25°C with excursions permitted between 15° to 30°C. The medication guide should be provided separately to each patient. It is distributed by Aurobindo Pharma USA, Inc. and it's made in India.*

This is a description of Divalproex Sodium, a medication that comes in the form of delayed-release tablets. Each tablet contains Diviproex sodium USP which is equivalent to Vaproi acid 250mg. The usual dosage should be checked from the package enclosure for prescribing information. It is advised to store at a temperature between 20°C to 25°C (68°F to 77°F) but excursions are permitted from 10°C to 15°C (89°F to 86°F). The unit-dose package is resistible to air and light. The text contains information about the manufacturer of the medicine which is Aurobindo, India. The package contains 100 tablets of 10 x 10 unit-dose each, which is distributable by a pharmacist alongside a medication guide packaged separately for each patient.*

Each tablet contains 500mg of Divalproex sodium USP, equivalent to valproic acid. It is distributed by Aurobindo Pharma USA, Inc. and comes in an enteric-coated delayed-release form. The tablets should be stored at 20° to 25°C, with excursions up to 15° to 30°C permitted. The medication guide must be provided to each patient, and the bottle should not be accepted if the seal over the bottle opening is broken or missing. This medication is intended for usual dosage, and complete dosing information can be found in the enclosure.*